Harry Kovelman insider trades
Open-market stock purchases and sales by Harry Kovelman, Chief Medical Officer at Myomo, Inc, from SEC Form 4 filings since Jun 9, 2021.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +72%.
Companies traded
- MYO Myomo, Inc: 1 buy, 7 sales, last Jun 12, 2026